- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AstraZeneca PLC
Recent news which mentions AstraZeneca PLC
From CNBC.com News
From CNBC.com News
From CNBC.com News
As Brits reel from a cost-of-living crisis, the UK stock market quietly booms to an all-time high
February 10, 2023
From CNBC.com News
As demand for Covid vaccines falls, AstraZeneca lines up 'blockbuster' products for 2023
February 09, 2023
From CNBC.com News
FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariants
January 26, 2023
From CNBC.com News
Lab Notes: Neuronetics resolves lawsuit; Harmony CEO departs; Ocugen issues results of Covaxin study
January 13, 2023
Tickers
INNO
From Business Journals
Biden administration will select first 10 drugs for Medicare price negotiations by September
January 11, 2023
From CNBC.com News
AstraZeneca reaches deal to buy CinCor Pharma for up to $1.8B
January 09, 2023
From Business Journals
Stocks making the biggest moves premarket: General Electric, Salesforce, Alibaba and more
January 04, 2023
From CNBC.com News
AstraZeneca acquires rights to potential COPD treatment in deal valued at up to $402M
November 28, 2022
From Business Journals
Stocks making the biggest moves midday: Six Flags, Rivian, Bumble, Coinbase, Dutch Bros and more
November 10, 2022
From CNBC.com News
From CNBC.com News
Omicron subvariants are resistant to key antibody treatments, putting people with weak immune systems at risk of Covid
October 27, 2022
From CNBC.com News
Covid vaccination linked to slight increase in menstrual cycle, NIH study confirms
September 28, 2022
From CNBC.com News
Stocks making the biggest moves premarket: FedEx, International Paper, Uber and more
September 16, 2022
From CNBC.com News
Stocks making the biggest moves premarket: Coupa, UiPath, Nio and more
September 07, 2022
From CNBC.com News
Markets face what could be the most important week of summer with Fed, earnings and economic data
July 22, 2022
From CNBC.com News
From CNBC.com News
From Business Journals
Stocks making the biggest moves premarket: Tesla, Occidental Petroleum, Exxon Mobil and more
July 05, 2022
From CNBC.com News
From CNBC.com News
From CNBC.com News
Cramer's lightning round: AstraZeneca is a pass
April 20, 2022
From CNBC.com News
Some of the first quarter’s biggest losers could be the biggest steals, Jim Cramer says
April 04, 2022
From CNBC.com News
AstraZeneca takes stake in a start-up that helps doctors conduct clinical trials virtually
March 23, 2022
From CNBC.com News
Covid was declared a pandemic two years ago and now we're finally moving on — but public health experts say it's not over
March 11, 2022
From CNBC.com News
From CNBC.com News
European markets set for muted open as investors monitor omicron risk
December 22, 2021
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.